Levels of Zinc and Lipid Peroxidation in Acute Coronary Syndrome

Biological Trace Element Research

Volumn 96, Issue 1-3, 2003, Pages 61-69

  Cikim, Gurkan ^a   Canatan, Halit ^b   Gursu, M Ferit ^b   Gulcu, Funda ^b   Baydas, Giyaseddin ^b   Kilicoglu, A Erhan ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Lipid peroxidation; MDA; Zinc

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; ZINC;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; PATIENT MONITORING; STATISTICAL SIGNIFICANCE; ZINC BLOOD LEVEL;

ACUTE DISEASE; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CORONARY DISEASE; FEMALE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; ZINC;

EID: 1642439265     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:96:1-3:61     Document Type: Article

References (27)

1. S. Sans, H. Kesteloot, and D. Kromhout, The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe, Eur. Heart J. 18, 1231-1248 (1997).
2. M. J. Davies, The role of plaque pathology in coronary trombosis, Clin. Cardiol. 20, 12-17 (1997).
3. M. J. Davies, A macro and micro view of coronary vascular insult in ischemic heart disease, Circulation 82, 1138-1146 (1990).
4. G. Cikim, Investigation of new risk factors and dyslipidemies in patients with coronary heart disease, Medical Residency thesis, College of Medicine, Firat University, Elazig, Turkey (2002).
5. V. Fuster, L. Badimon, J. J. Badimon, et al., The pathogenesis of coronary artery disease and the acute coronary syndromes (1), N. Engl. J. Med. 326, 242-250 (1992).
6. R. A. Jacob and B. J. Burri, Oxidative damage and defense, Am. J. Clin. Nutr. 63, 985-990 (1996).
7. J. M. Gutteridge, Lipid peroxidation and antioxidants as biomarkers of tissue damage, Clin. Chem. 41, 1819-1828 (1995).
8. M. D. Stringer, P. G. Gorog, A. Freeman, et al., Lipid peroxides and atherosclerosis, Br. Med. J. 298, 281-284 (1989).
9. A. H. Wyllie, E. Duvall, Cell injury and death. In: JO'D Mcgee, P. G. Isaacson, N. A. Wright. Oxford Textbook of Pathology. New York: Oxford University Press, 141-193 (1992).
10. S. Meraji, P. M. Abuja, M. Hayn, et al., Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran, Atherosclerosis 150, 403-412 (2000).
11. H. Esterbauer, G. Wag, and H. Puhl, Lipid peroxidation and its role in atherosclerosis, Br. Med. Bull. 49, 566-576 (1993).
12. B. Hennig, Y. Wang, S. Ramasamy, et al., Zinc deficiency alters barrier function of cultured porcine endothelial cells, J. Nutr. 122, 1242-1247 (1992).
13. R. J. Maughan, Role of micronutrients in sport and physical activity, Br. Med. Bull. 55, 683-690 (1999).
14. D. Konig, J. Keul, H. Northoff, et al., Effect of 6-week nutritional intervention with enzymatic yeast cells and antioxidants on exercise stress and antioxidant status, Wien. Med. Wochenschr. 149, 13-18 (1999).
15. J. Clair, R. Talwalkar, C. J. McClain, et al., Selective removal of zinc from cell culture media, J. Trace Elements Exp Med. 7, 143-151 (1995).
16. C. Lopez, D. C. Ocon, M. S. Mengo, et al., Study of zinc and copper serum levels in dislipemias, Therapie 46, 17-20 (1991).
17. O. Oster, Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy, Clin. Chim. Acta. 214, 209-218 (1993).
18. A. Golik, N. Cohen, Y. Ramot, et al., Type II diabetes mellitus, congestive heart failure, and zinc metabolism, Biol. Trace Element Res. 39, 171-175 (1993).
19. T. Magalova, A. Brtkova, A. Bederova, et al., Serum copper and zinc in industrial centers in Slovakia, Biol. Trace Element Res. 40, 225-235 (1994).
20. M. Tokdemir, S. A. Polat, Y. Acik, et al., Comparison of blood zinc and copper concentrations in criminal and non criminal schizophrenic patients, Arch. Androl. 49, 365-368.
21. K. Satoh, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clin. Chim. Acta. 90, 37-43 (1978).
22. G. Baydas, M. F. Gursu, S. Yilmaz, et al., Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats, Neurosci. Lett. 323, 195-198 (2002).
23. J. Loeper, J. Goy, L. Rozensztajn, et al., Lipid peroxidation and protective enzymes during myocardial infarction, Clin. Chim. Acta. 196, 119-125 (1991).
24. S. R. Maxwell and G. Y. Lip, Free radicals and antioxidants in cardiovascular disease, Br. J. Clin. Pharmacol. 44, 307-317 (1997).
25. W. Cai, B Devaux, W. Schaper, et al., The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions, Atherosclerosis 131, 177-186 (1997).
26. E. Gomez, C. del Diego, I. Orden, et al., Longitudinal study of serum copper and zinc levels and their distribution in blood proteins after acute myocardial infarction, J. Trace Elements Med. Biol. 14, 65-70 (2000).
27. B. Hennig, M. Toborek, and C. J. Mcclain, Antiatherogenic properties of zinc: implications in endothelial cell metabolism, Nutrition 12, 711-717 (1996).